177 related articles for article (PubMed ID: 17950274)
1. IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Berković MC; Jokić M; Marout J; Radosević S; Zjacić-Rotkvić V; Kapitanović S
Exp Mol Pathol; 2007 Dec; 83(3):474-9. PubMed ID: 17950274
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors.
Berković M; Cacev T; Zjacić-Rotkvić V; Kapitanović S
Neuroendocrinology; 2006; 84(5):346-52. PubMed ID: 17164537
[TBL] [Abstract][Full Text] [Related]
3. IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).
Berković MC; Jokić M; Marout J; Radosević S; Zjacić-Rotkvić V; Kapitanović S
J Mol Med (Berl); 2010 Apr; 88(4):423-9. PubMed ID: 20049409
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract][Full Text] [Related]
5. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
6. NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors.
Burnik FS; Yalçin S
Chemotherapy; 2009; 55(5):381-5. PubMed ID: 19752553
[TBL] [Abstract][Full Text] [Related]
7. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.
Belli SH; Oneto A; Aranda C; O'Connor JM; Domenichini E; Roca E; Méndez G; Bestani MC; Parma P; Giacomi N; Marmissolle F
Acta Gastroenterol Latinoam; 2009 Sep; 39(3):184-9. PubMed ID: 19845257
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
Bittar MN; Carey JA; Barnard J; Fildes JE; Pravica V; Yonan N; Hutchinson IV
Heart Surg Forum; 2005; 8(3):E140-5; discussion E145. PubMed ID: 16183563
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis CG; Caplin ME
Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer].
Qi T; Wang Q; Zheng L; Yang HL; Bao J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):754-7. PubMed ID: 18504197
[TBL] [Abstract][Full Text] [Related]
12. -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer.
Belluco C; Olivieri F; Bonafè M; Giovagnetti S; Mammano E; Scalerta R; Ambrosi A; Franceschi C; Nitti D; Lise M
Clin Cancer Res; 2003 Jun; 9(6):2173-6. PubMed ID: 12796383
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6-174 G/C polymorphism is not associated with IL-6 expression and susceptibility to sporadic colon cancer.
Cacev T; Jokić M; Loncar B; Krizanac S; Kapitanović S
DNA Cell Biol; 2010 Apr; 29(4):177-82. PubMed ID: 20132036
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study.
Zatelli MC; Torta M; Leon A; Ambrosio MR; Gion M; Tomassetti P; De Braud F; Delle Fave G; Dogliotti L; degli Uberti EC;
Endocr Relat Cancer; 2007 Jun; 14(2):473-82. PubMed ID: 17639060
[TBL] [Abstract][Full Text] [Related]
16. Cytokine genotypes in acute pancreatitis: association with etiology, severity, and cytokine levels in blood.
de-Madaria E; Martínez J; Sempere L; Lozano B; Sánchez-Payá J; Uceda F; Pérez-Mateo M
Pancreas; 2008 Oct; 37(3):295-301. PubMed ID: 18815552
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6.
Tischendorf JJ; Yagmur E; Scholten D; Vidacek D; Koch A; Winograd R; Gressner AM; Trautwein C; Wasmuth HE; Lammert F
Int J Immunogenet; 2007 Dec; 34(6):413-8. PubMed ID: 18001296
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients.
Sainz J; Pérez E; Gómez-Lopera S; López-Fernández E; Moratalla L; Oyonarte S; Jurado M
Cytokine; 2008 Mar; 41(3):268-78. PubMed ID: 18191407
[TBL] [Abstract][Full Text] [Related]
19. Gastroenteropancreatic endocrine tumors.
Meeker A; Heaphy C
Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
[TBL] [Abstract][Full Text] [Related]
20. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma.
Wei YS; Lan Y; Luo B; Lu D; Nong HB
Mol Carcinog; 2009 Aug; 48(8):751-7. PubMed ID: 19148899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
